Hip Replacement Recall Involves Lanier, Johnson & Johnson

LOS ANGELES – The Lanier Law Firm is providing information for patients following the announcement that Johnson & Johnson (NYSE: JNJ) is recalling two hip replacement implants based on the high number of people requiring a second surgery. Attorneys from the firm have more than a decade of experience in hip implant replacement cases.

On the website www.recalledhip.com, The Lanier Law Firm provides news and details about the latest recall from Johnson & Johnson in addition to information for concerned patients and their families. Over the last decade, thousands of consumers have visited www.recalledhip.com for important news and information, including FDA updates and manufacturer information about hip implant recalls.

The recalled implants were manufactured by Johnson & Johnson’s DePuy Orthopaedics Inc. unit, and include the ASR XL Acetabular System and DePuy ASR Hip Resurfacing System. More than 93,000 patients purchased the two implants before the company stopped production last year. Johnson & Johnson recorded worldwide sales of nearly $62 billion in 2009, with its DePuy unit accounting for more than $5 billion.

The Lanier Law Firm is one of the country’s top trial law firms. In 2001, attorneys from the firm helped hundreds of people who faced a second, “explant” surgery to remove defective Inter-Op brand hip replacement implants sold by Sulzer Orthopedics. The Sulzer recall resulted in a nationwide settlement of $1.2 billion for patients.

A recent study revealed that more than 10 percent of patients with the ASR XL Acetabular System  and DePuy ASR Hip Resurfacing System have required corrective surgery within five years of their original procedures. The recalled implants include metal-on-metal contact, which has been criticized by surgeons because of the likelihood of metal shavings causing problems in surrounding tissue.

Acclaimed trial lawyer and firm founder Mark Lanier says: “Johnson & Johnson is a huge company that should know better but they’ve kept pushing this dangerous product despite the obvious problems.”